Cynthia Levy

39PUBLICATIONS
159CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Liquid biopsiesPredictive and prognostic markersEconometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Apr 13, 2026
Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Apr 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Adrielly Martins, Anish Reddy, Richard Dean

|Apr 06, 2026
Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.

Cynthia Levy, Christopher L Bowlus, Eric Lawitz

|Mar 02, 2026
Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

Anish Reddy, Adrielly Martins, Christopher L Bowlus

|Nov 12, 2025
Comment on Ejaz et al. Letter to the Editor.

Cynthia Levy, Marlyn J Mayo, C Fiorella Murillo Perez

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

Pageof 7